Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis

Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis

Anti-NMDA receptor encephalitis is the most common type of antibody mediated autoimmune encephalitis (AIE). Patients often develop neuropsychiatric symptoms and seizures, women are affected about four times more than men, and in about 50% the disease is associated with a neoplasia, especially terato...

Full description

Bibliographic Details
Main Authors: Dominica Ratuszny, Thomas Skripuletz, Florian Wegner, Matthias Groß, Christine Falk, Roland Jacobs, Heiner Ruschulte, Martin Stangel, Kurt-Wolfram Sühs
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Neurology
Subjects:
anti-NMDA receptor encephalitis
autoimmune encephalitis
bortezomib
daratumumab
critical care
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.602102/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2020.602102/full

Similar Items